We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Puretech Health Plc | LSE:PRTC | London | Ordinary Share | GB00BY2Z0H74 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 169.40 | 169.00 | 171.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Home Health Care Services | 65.12M | -65.7M | -0.2744 | -6.17 | 405.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/4/2024 07:09 | We consistently maintain one of the most impressive track records in the biopharma industry, with a probability of clinical success that is six times higher than the industry average3. More than 80 percent4 of our clinical trials have demonstrated success, and we take great pride in this track record. Across our programs, this has delivered a robust pipeline of new medicines that are poised for growth. This includes 29 new therapeutics and therapeutic candidates generated to date Really do think its time they upped their game..lol | ohisay | |
25/4/2024 06:27 | Results are out, had a quick scan and it all looks awesome with this tucked away at the end "These achievements underscore the significant value we have created that has not been fully recognized by the market. I am committed to evaluating ways to unlock and crystalize that value for shareholders and look forward to sharing my vision for the Company's future growth in the coming months." | return_of_the_apeman | |
22/4/2024 15:00 | Strange that Puretech are back down to the 2 pound level. Taken some in anticipation of positive market reaction to results on Thursday. More info on tender offer would be welcome! | swinsco | |
22/4/2024 10:45 | Oxb starting to motor now I see prtc pulled up at the 1st 🐎 | linton5 | |
19/4/2024 11:38 | Chazzzyt: and how is the share price going to rise. | rogers49 | |
19/4/2024 11:13 | Why are they cheap is the question. | chazzyt | |
19/4/2024 08:59 | More for me this morning..remarkably cheap. | ohisay | |
18/4/2024 10:04 | My broker said easily sorted on the form | edwardt | |
16/4/2024 15:14 | I can wait for that! | edwardt | |
16/4/2024 15:11 | Data read out for LYT100 is still 6 months away.Will definitely move the needle if successful. | colinblackbourn | |
16/4/2024 11:35 | What has Puretech got to do to interest investors.Nothing has shaken the tree in years.Zohar moving on has upset long term investors and the 2 50 offer is embarrassing.The Peel Hunt boys must be on the wakky bakky | chazzyt | |
16/4/2024 11:19 | A good update on the enrollment of lyt 100 | linton5 | |
15/4/2024 15:31 | From your broker | crazycoops | |
15/4/2024 15:31 | There are several companies that are UK listed (e.g. SPSY, SOM) that are US based and the US tax rules for withholding tax apply. I presume the same is true for PRTC being headquartered in Boston. | crazycoops | |
15/4/2024 14:49 | Are we considered US based, surely primary uk listing means we are uk from a WHT perspective | rimau1 | |
15/4/2024 14:35 | Where do I get one of those from?! | edwardt | |
15/4/2024 11:16 | I just picked this up from Mark Simpson on Stockopedia. To avoid withholding tax on a tender offer from a US based company, investors will need to complete a Section 302 "Certification of Treatment of Tender Payment" form. This is separate from a W-8BEN form that most investors will already be familiar with. Worth noting for anyone considering taking up the PRTC tender offer. | crazycoops | |
15/4/2024 07:08 | You’ve got to laugh at this manipulation 🫶🏻 | brianblu | |
11/4/2024 14:21 | Needs more US buyers. | colinblackbourn | |
11/4/2024 13:54 | Peel Hunt needs to get their Institution clients to start buying. | rogers49 | |
11/4/2024 12:10 | Peel Hunt currently has a 930p target.PureTech is their top pick in the healthcare sector.If the tender offer goes ahead at 250p..their pro forma asset value goes from 930p to 1040p with $100m less cash and 14pc fewer shares in issue. | colinblackbourn | |
11/4/2024 11:19 | Gallop...100pc owned Oncology division is another candidate for the VC treatment and spin off. | colinblackbourn | |
11/4/2024 11:09 | More good news All the same immensely undervalued puretech | brianblu |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions